For the past three years, nearly every breakthrough in obesity medicine has traced back to a single class of drugs: GLP-1 ...

Starting July 2026, Medicare will launch the temporary GLP-1 Bridge program, offering limited coverage for weight-loss drugs like Wegovy and Zepbound under certain conditions. The pilot, running ...

The Trump administration decided to put the pilot on hold until at least 2027.

NEW YORK – PrecisionLife and Ovation.io on Wednesday said they inked an agreement to launch a consumer-facing genetic test for identifying patients' likelihood of responding to GLP-1 receptor agonists ...

There is no shortage of headlines about GLP-1 medications. Originally developed to manage blood sugar levels, these medications are now widely known for promoting weight loss. Alongside their rapid ...

Weight loss drugs like GLP-1s are rapidly reshaping how Americans think about appetite, health and food – forcing CPG brands to reconsider everything from formulation to front-of-pack messaging.

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a ...

Could drugs like Mounjaro treat people with cannabis use disorder? They might. Preliminary research indicates they may stop ...